FR2187325A1 - Fat-soluble extract of beet - for treatment of Raynaud's disease, vascular degeneration and metabolic disorders - Google Patents

Fat-soluble extract of beet - for treatment of Raynaud's disease, vascular degeneration and metabolic disorders

Info

Publication number
FR2187325A1
FR2187325A1 FR7221516A FR7221516A FR2187325A1 FR 2187325 A1 FR2187325 A1 FR 2187325A1 FR 7221516 A FR7221516 A FR 7221516A FR 7221516 A FR7221516 A FR 7221516A FR 2187325 A1 FR2187325 A1 FR 2187325A1
Authority
FR
France
Prior art keywords
beet
fat
soluble extract
raynaud
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7221516A
Other languages
French (fr)
Other versions
FR2187325B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SARB
Original Assignee
SARB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SARB filed Critical SARB
Priority to FR7221516A priority Critical patent/FR2187325A1/en
Publication of FR2187325A1 publication Critical patent/FR2187325A1/en
Application granted granted Critical
Publication of FR2187325B1 publication Critical patent/FR2187325B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Therapeutic compsns contain as active component (I) a fat-soluble extract of sugar beet. It is extracted from beet, e.g after extraction of sugar by light petroleum, the solvent evaporated and the residue treated with alkaline aqs. ethanol. Administration may be oral or topical.
FR7221516A 1972-06-12 1972-06-12 Fat-soluble extract of beet - for treatment of Raynaud's disease, vascular degeneration and metabolic disorders Granted FR2187325A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7221516A FR2187325A1 (en) 1972-06-12 1972-06-12 Fat-soluble extract of beet - for treatment of Raynaud's disease, vascular degeneration and metabolic disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7221516A FR2187325A1 (en) 1972-06-12 1972-06-12 Fat-soluble extract of beet - for treatment of Raynaud's disease, vascular degeneration and metabolic disorders

Publications (2)

Publication Number Publication Date
FR2187325A1 true FR2187325A1 (en) 1974-01-18
FR2187325B1 FR2187325B1 (en) 1975-10-17

Family

ID=9100220

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7221516A Granted FR2187325A1 (en) 1972-06-12 1972-06-12 Fat-soluble extract of beet - for treatment of Raynaud's disease, vascular degeneration and metabolic disorders

Country Status (1)

Country Link
FR (1) FR2187325A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0271133A1 (en) * 1986-11-19 1988-06-15 Bar Ilan University Antioxidant compositions and methods of using them

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0271133A1 (en) * 1986-11-19 1988-06-15 Bar Ilan University Antioxidant compositions and methods of using them

Also Published As

Publication number Publication date
FR2187325B1 (en) 1975-10-17

Similar Documents

Publication Publication Date Title
GB1092269A (en) Hydroxyflavan 3,4-diols and medicaments based thereon
ES532515A0 (en) A PROCEDURE FOR THE PREPARATION OF NIFEDIPINE DRUG FORMULATIONS IN TWO PHASES, FOR THE TREATMENT OF CIRCULATORY AND CORONARY DISEASES.
IL65875A0 (en) Capsules containing the active principle of an allergen,and process for their preparation
Day The release of substances like acetylcholine and adrenaline by the isolated rabbit heart
FR2187325A1 (en) Fat-soluble extract of beet - for treatment of Raynaud's disease, vascular degeneration and metabolic disorders
GB1115369A (en) An artificial tobacco free from nicotine
Viukari et al. Effect of methyldopa on tardive dyskinesia in psychogeriatric patients.
FR2302745A1 (en) Extracting caffeic acid heteroside esters - from plants, useful as potentiators for L-dopa
FR2187321A1 (en) Flavoured extract of water lilies - with antihaemorrhagic activity
GB1108245A (en) A diuretic antitoxic and mental-stimulating extract of mammalian brain and a process for its production
Zung Antidepressant drugs and sleep in depressive disorders.
RU2003338C1 (en) Remedy showing cholagogic action
GB337797A (en) A specific for cancer
Grewel et al. Diagnosis and treatment of speaking and language disorders following cerebral injury in old age.
Maller et al. Neutralization of extrapyramidal side-effects with methixene.
Jirgl et al. The influence of propericiazine on the behavior of difficult delinquents.
GB1129134A (en) Improvements in compositions containing nicotinates
FR2576M (en) New drug, in particular for the treatment of blood coagulability disorders.
DE953644C (en) Method of making a medicinal product
Sharma et al. Value as a function of regression and sex.
AU432652B2 (en) Pharmaceutical compositions suitable for cicoatrization processes and forthe treatment of physiological disorders ofthe skin
Tsvetkova Disturbance of active forms of speech in dynamic aphasia.
Dengrove Therapeutic approaches of impotence in the male: III. Behavior therapy of impotence.
AU2603567A (en) Pharmaceutical compositions suitable for cicoatrization processes and forthe treatment of physiological disorders ofthe skin
Spierings et al. Flunarizine Versus Pizotifen In Migraine Prophylaxis: A Review Of Comparative Studies

Legal Events

Date Code Title Description
CA Change of address
ST Notification of lapse